These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3978058)

  • 41. Radioimmunoscintigraphy of ovarian cancer.
    Granowska M; Britton KE
    Dis Markers; 1991; 9(3-4):191-5. PubMed ID: 1725973
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunolocalization of anti-placental alkaline phosphatase monoclonal antibody in mice with testicular tumors and lymph node metastasis.
    Koshida K; Yokoyama K; Imao T; Konaka H; Hirano K; Uchibayashi T; Namiki M
    Urol Res; 1998; 26(1):23-8. PubMed ID: 9537692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.
    Kalofonos HP; Pawlikowska TR; Hemingway A; Courtenay-Luck N; Dhokia B; Snook D; Sivolapenko GB; Hooker GR; McKenzie CG; Lavender PJ
    J Nucl Med; 1989 Oct; 30(10):1636-45. PubMed ID: 2795204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification and characterisation of the placental-like alkaline phosphatase from ovarian epithelial tumours.
    Koyama I; Hirano K; Makiya R; Stendahl U; Stigbrand T
    Br J Cancer Suppl; 1990 Jul; 10():6-11. PubMed ID: 2383481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for homology of normal and neoplastic human placental alkaline phosphatases as determined by monoclonal antibodies to the cancer-associated enzyme.
    Jemmerson R; Shah N; Fishman WH
    Cancer Res; 1985 Jul; 45(7):3268-73. PubMed ID: 2408748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies.
    Millán JL; Stigbrand T
    Eur J Biochem; 1983 Oct; 136(1):1-7. PubMed ID: 6193958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and characterization of monoclonal antibodies against placental alkaline phosphatase and other human trophoblast-associated determinants.
    Travers P; Bodmer W
    Int J Cancer; 1984 May; 33(5):633-41. PubMed ID: 6202646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eutopic expression of placental-like alkaline phosphatase in testicular tumors.
    Jeppsson A; Wahren B; Brehmer-Andersson E; Silfverswärd C; Stigbrand T; Millán JL
    Int J Cancer; 1984 Dec; 34(6):757-61. PubMed ID: 6511123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments.
    Taylor DD; Homesley HD; Doellgast GJ
    Cancer Res; 1980 Nov; 40(11):4064-9. PubMed ID: 7008934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors contributing to imaging of xenografts using anti-placental alkaline phosphatase monoclonal antibody.
    Koshida K; Yokoyama K; Uchibayashi T; Yamamoto H; Hirano K; Namiki M
    J Urol; 1997 May; 157(5):1941-5. PubMed ID: 9112568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibodies for successful tumour imaging.
    Burchell J; Taylor-Papadimitriou J; Granowska M; Britton K
    Behring Inst Mitt; 1984 May; (74):87-93. PubMed ID: 6541035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A monoclonal antibody that reacts with nonallelic enzyme glycoproteins.
    Gogolin KJ; Wray LK; Slaughter CA; Harris H
    Science; 1982 Apr; 216(4541):59-61. PubMed ID: 6175022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening of sera and tumor extracts of cancer patients using a monoclonal antibody directed against human placental alkaline phosphatase.
    Van de Voorde A; de Groote G; de Waele P; de Broe ME; Pollet D; de Boever J; Vandekerckhove D; Fiers W
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):65-71. PubMed ID: 3882432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.
    Pateisky N; Philipp K; Sevelda P; Skodler WD; Enzelsberger H; Hamilton G; Burchell J; Schatten C
    Gynecol Obstet Invest; 1987; 24(3):211-6. PubMed ID: 3692333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging of ovarian cancer with radiolabelled monoclonal antibodies.
    van Kranenburg DL; van Kroonenburgh MJ; Trimbos JB; Fleuren GJ; Pauwels EK
    Arch Gynecol Obstet; 1990; 247(3):107-16. PubMed ID: 2142403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.
    Toftager-Larsen K; Hørding U; Dreisler A; Daugaard S; Lund B; Bock J; Lundvall F; Frederiksen K; Nørgaard-Pedersen B
    Gynecol Obstet Invest; 1992; 33(3):177-82. PubMed ID: 1319386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Placental-like alkaline phosphatase from ovary and ascites of a patient with a malignant ovarian tumour.
    Koyama I; Stendahl U; Stigbrand T
    Clin Chim Acta; 1990 Jan; 186(2):295-9. PubMed ID: 2311257
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunological relationship between human placental and intestinal alkaline phosphatase.
    Lehmann FG
    Clin Chim Acta; 1975 Dec; 65(3):257-69. PubMed ID: 1204218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimizing the generation of recombinant single-chain antibodies against placental alkaline phosphatase.
    Sheikholvaezin A; Sandström P; Eriksson D; Norgren N; Riklund K; Stigbrand T
    Hybridoma (Larchmt); 2006 Aug; 25(4):181-92. PubMed ID: 16934014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibodies against placental-like and intestinal-like alkaline phosphatases in a malignant human cell line.
    Wray LK; Harris H
    Eur J Biochem; 1984 Mar; 139(3):503-8. PubMed ID: 6698027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.